ISSN 3080-7611(Print)
ISSN 3080-762X(Online)
版权信息 · Copyright

     加入编委 / 副主编 / 同行评议专家
ISSN 3080-7611(Print)
ISSN 3080-762X(Online)

CODEN:ZLYABX
国际标准连续出版物标识符·全球唯一标识符
分配机构:美国化学文摘社(CAS)
DOI前缀:
https://doi.org/10.66106/zlyabx
国图集团 CIBTC
进口备案刊号:G015Z110

索引 检索 存档(Global Indexing)
本刊入选以下全球权威数据库,致力于研究成果的全球化无障碍传播。

CNKI(中国知网,申请中)
CNKI Open(中国知网·开放平台,申请中)
Wanfang Data(万方数据,中国,更新中)
CQVIP(维普期刊网,中国)
CQVIP(中文期刊服务平台,中国)
RCCSE(中国学术期刊目录,武汉大学)
CJWK(长江文库,中国)
BOOKAN(博看,中国)
591adb(中邮阅读·万章期刊,中国)
Baidu Scholar(百度学术,中国)
Baidu Baike(百度百科,中国)
ICI(哥白尼期刊数据库,波兰)
EuroPub(欧洲学术出版数据库,英国)
MDPI scilit(科学与学术数据库,瑞士)
Crossref(交叉引用,美国)
Semantic Scholar(语义学术,美国)
OpenAlex(全球开源学术平台,加拿大)
ACADEMIA.EDU(学术界,美国)
OUCI(开放乌克兰科学,乌克兰)
WorldCat(世界编目数据库,美国)
Scite(智能引文分析数据库,美国)
The Lens(透镜学术,澳大利亚)
OpenAIRE(开放学术发现门户,欧洲)
Google Scholar(谷歌学术,美国)
DOI(数字对象唯一标识符,英国)
Portico(数字存储库,美国)
J-Gate(开放获取期刊门户,印度)
ResearchGate(研究之门,德国)
Research Commons(科睿唯安,美国)
Socolar(开放获取资源检索,中国,更新中)
Sci Online(科学在线,中国澳门)
OALib(开放存取资源图书馆,美国)
EZB(电子期刊图书馆,德国,申请中)
Road(开放科学学术资源,法国)
ISI(国际科学索引平台,阿联酋迪拜)
ASCI(亚洲科学引文索引,美国)
ESJI(欧亚科学期刊索引,哈萨克斯坦)
ResearchBib(研究者索引,日本)
SPI-Hub™(范德比尔特大学,美国)
SJIF(科学期刊影响因子,印度)
RJIF(研究期刊影响因子)
COSMOS(期刊评价指标,印度)
LivRe!(开放期刊门户,巴西)
KIND CONGRESS(阿塞拜疆)
Journament(质量评估与索引)
IP Indexing(ip索引)
Magzter(跨平台数字期刊,美国)
SlideShare(知识共享平台,美国)
SCRIBD(在线图书馆,美国)
Yahoo! Search(雅虎,美国)
Microsoft Bing(微软学术,美国)
LibKey(学术文献快捷获取工具)
R Discovery(研究者发现平台,印度)
Enterscholar(恩特学术)

规划申请

SinoMed 中国生物医学文献服务系统
EBSCO 学术文献数据库(美国)

CABI 国际农业与生物科学中心(英国)
RePEc 经济研究文献数据库(美国)
OAJ 全球OA期刊索引(中国)
DOAJ 开放获取期刊目录(瑞典)
PubMed 医学文摘数据库(美国)
PubMed Central 医学全文数据(美国)
Scopus 爱思唯尔·斯高帕斯(荷兰)
EMBASE 爱思唯尔·医学文摘(荷兰)
ProQuest 科睿唯安(美国)
Research4Life 世界卫生组织数据库

Editing and Publishing
Quest Press Limited
Address
Unit D, 7th Floor, No. 19, Rua de Pa̍k-chiông Vai, Macau
Telephone
+853 6881 9699
Email
QuestPress@hotmail.com
Web site
https://zwlc.scionline2025.com
  往期阅览 · All Issues-> 2025年 · 2025  
中外临床医学2025年第1卷第1期第56-60页,pISSN 3080-7611、eISSN 3080-762X 发布者:Quest Press 发布日期:2025/10/9
Open Access 浏览407

 

毛发移植联合生长因子治疗瘢痕脱发患者的临床疗效观察


高俊伟

北京八大处第二医疗美容医院,北京,100000

摘要:目的? 探讨毛发移植联合生长因子治疗瘢痕脱发患者的临床疗效。方法? ? 选取2021年10月至2023年10月我院收治的瘢痕脱发患者86例,随机分为观察组和对照组,每组43例,对照组采用单纯毛发移植治疗,观察组采用毛发移植联合生长因子治疗,均治疗6个月。采用瘢痕性脱发严重程度评分量表(SALT)评估患者治疗前后的差异,观察两组患者治疗前及治疗后6个月的毛发密度、毛发直径、毛囊成活率、终毛与毳毛比例、毛发抗拉强度、毛发光泽度、不良反应发生率,并采用视觉模拟评分法(VAS)评估患者满意度。结果? 治疗前,两组SALT评分差异无统计学意义(P>0.05)。治疗后6个月,观察组SALT评分显著低于对照组(P<0.05)。观察组毛发密度,毛发直径,毛囊成活率,终毛与毳毛比例,毛发抗拉强度,毛发光泽度评分均高于对照组(P<0.05)。观察组不良反应发生率为4.65%(2/43)低于对照组的18.60%(8/43),P=0.001。观察组患者满意度VAS评分高于对照组(P<0.05)。结论? 毛发移植联合生长因子治疗瘢痕脱发患者可显著提高临床疗效,改善毛发质量相关指标,降低病情严重程度,降低不良反应发生率,提高患者满意度,具有较好的临床应用价值。

关健词:毛发移植;生长因子;瘢痕脱发;临床疗效
Clinical observation of hair transplantation combined with growth factor in the treatment of cicatricial alopecia

Junwei Gao

Beijing Badachu Second Medical Aesthetics Hospital, Beijing 100000,China

Abstract:Objective To investigate the clinical effect of hair transplantation combined with growth factor in the treatment of cicatricial alopecia. Methods A total of 86 patients with cicatricial alopecia treated in our hospital from October 2021 to October 2023 were randomly divided into observation group and control group, 43 cases in each group. The control group was treated with hair transplantation alone, and the observation group was treated with hair transplantation combined with growth factor for 6 months. The difference before and after treatment was assessed by the severity of cicatricial alopecia severity scale (SALT). Hair density, hair diameter, hair follicle survival rate, the ratio of terminal hair to ffne hair, hair tensile strength, hair gloss and incidence of adverse reactions of the two groups were observed before and 6 months after treatment. Patient satisfaction was assessed by visual analog scale (VAS). Results Before treatment, there was no signiffcant difference in SALT score between the two groups (P>0.05). At 6 months after treatment, SALT score of observation group was signiffcantly lower than that of control group (P<0.05).Conclusion Hair transplantation combined with growth factor in the treatment of cicatricial alopecia patients can signiffcantly improve clinical efffcacy, improve hair-quality related indicators, reduce the severity of the disease, reduce the incidence of adverse reactions, improve patient satisfaction, and have good clinical application value.


Keywords : Hair transplantation; Growth factor; Cicatricial alopecia; Clinical effect
论文收录证明 / 文献检索报告
Document Retrieval Certificate / Proof of Publication Indexing
作者贡献声明 / 贡献确认书
Author Contribution Statement / Certificate of Authorship Contribution
同行评审报告 / 评审意见
Peer Review Report / Peer Review Comments
利益冲突
Conflict of Interest
作者声明不存在任何利益冲突。
The author declares no conflict of interest.
版权声明
Copyright Statement
本文采用知识共享“署名 4.0 国际”许可 (CC BY 4.0) 进行许可。许可协议详情请访问: https://creativecommons.org/licenses/by/4.0/
This article is licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0). For details of the license, please visit:https://creativecommons.org/licenses/by/4.0/.

 
Peer Review
同行评审
Editorial Services
编辑服务
Research Ethics Policy
研究伦理政策
Contributorship & Authorship
贡献者与署名
Quest Press / Macau Sino-Foreign Medical Publishing Ltd.
关于 Quest Press / Macau Sino-Foreign Medical Publishing Ltd.
Global Indexing
全球索引
Copyright Licensing
版权许可
Data Sharing Policy
数据共享政策
Appeal/Correction/Retraction
申诉/更正/撤回
Online Submission
线上投稿
To the Librarian
致图书馆员
Open Access Statement
开放获取声明
Misconduct Handling Policy
处理不端行为政策
Content Licensing
内容许可
Guidelines for Reviewers
审稿人指南
Quality Control Mechanism
质量把控机制
Academic Misconduct Screening Policy
学术不端筛查政策
Advertising Policy
广告政策
Article Processing Charge (APC)
文章处理费
Publication Ethics Policy
出版伦理政策
Joining the Editorial Board, Associate Editors, Peer Reviewers, and Editor-in-Chief
加入编委、副主编、同行评审专家及主编
Quest Press
Bridging Research to a Global Stage.
academia
© 2025-2026 Quest Press Ltd.
Address: Unit D, 7th Floor, No. 19, Rua de Pa̍k-chiông Vai, Macau
Tel: +853 6881 9699 / Email: QuestPress@hotmail.com
The QUEST PRESS publishes articles under the following open access license.
Quest Press
is a member of the following organizations.